Suchergebnisse - "Le Gars, Mathieu"

PubPharm (55)

1

B cell somatic hypermutation following COVID-19 vaccination with Ad26.COV2.S

enthalten in: iScience | 2024

von Jacob-Dolan, C. | Lifton, M. | Powers, O. | +13

2

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features

enthalten in: Nature communications | 2024

von Magaret, C. | Li, L. | deCamp, A. | +47

UpdateOf: Res Sq. 2023 May 31;:. - PMID 37398105

3

Mechanistic modeling projections of antibody persistence after homologous booster regimens of COVID-19 vaccine Ad26.COV2.S in humans

enthalten in: CPT: pharmacometrics & systems pharmacology | 2023

von Dari, A. | Jacqmin, P. | Iwaki, Y. | +6

4

Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccines

enthalten in: iScience | 2023

von Van Coillie, J. | Pongracz, T. | Šuštić, T. | +62

5

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features

enthalten in: Research square | 2023

von Magaret, C. | Li, L. | deCamp, A. | +40

UpdateIn: Nat Commun. 2024 Mar 11;15(1):2175. - PMID 38467646

6

Compositions and Methods for Preventing and Treating Coronavirus Infection - Sars-Cov-2 Vaccines

enthalten in: Europäisches Patentamt | 2023

von BAROUCH DAN H | LANGEDIJK JOHANNES PETRUS MARIA | RUTTEN LUCY | +7

7

Compositions and Methods for Preventing and Treating Coronavirus Infection - Sars-Cov-2 Vaccines

enthalten in: Europäisches Patentamt | 2023

von BAROUCH DAN H | LANGEDIJK JOHANNES PETRUS MARIA | RUTTEN LUCY | +7

8

Safety, reactogenicity, and immunogenicity of Ad26.COV2.S : Results of a phase 1, randomized, double-blind, placebo-controlled COVID-19 vaccine trial in Japan

enthalten in: Vaccine | 2023

von Tsuchiya, Y. | Tamura, H. | Fujii, K. | +6

9

Quantifying Antibody Persistence After a Single Dose of COVID-19 Vaccine Ad26.COV2.S in Humans Using a Mechanistic Modeling and Simulation Approach

enthalten in: Clinical pharmacology and therapeutics | 2023

von Dari, A. | Boulton, M. | Neyens, M. | +8

10

Quantifying Antibody Persistence After a Single Dose of COVID‐19 Vaccine Ad26. COV2.S in Humans Using a Mechanistic Modeling and Simulation Approach

enthalten in: Clinical Pharmacology & Therapeutics | 2023

von Dari, A. | Boulton, M. | Neyens, M. | +8

1
2
3
4
5
6
Nächster »
[6]